Skip to Content

Tag: Peter Farrell


Also Noted

ResMed officials sell shares

August 6, 2014HME News Staff

SAN DIEGO - ResMed Director Peter Farrell on Aug. 1 sold 25,000 shares of stock at an average price of $49.04 for a total transaction of about $1.23 million. Farrell now owns 279,990 shares valued at about $13.73 million. Also on Aug. 1, COO Robert Andrew Douglas sold 8,000 shares at an average price of $48.95 for a total transaction of $391,600. The day before the transactions, ResMed reported earnings for the fourth quarter and fiscal year ended June 30.

Earnings, Peter Farrell, ResMed, shares


Read Full Articlered right arrow icon

Also Noted

Farrell unloads ResMed stock

May 6, 2014HME News Staff

SAN DIEGO - Peter Farrell, the former CEO of ResMed and a current director, sold 25,000 shares of company stock on the open market in a transaction dated May 1. The stock was sold at $49.80 for a total value of $1.245 million. Farrell still owns 304,990 shares in the company valued at $15.188 million. The sale was disclosed in a document filed with the Securities & Exchange Commission.

Peter Farrell, ResMed, stock


Also Noted

ResMed founder named to CONNECT Hall of Fame

February 20, 2014HME News Staff

SAN DIEGO - ResMed Founder Peter Farrell has been inducted into the CONNECT Entrepreneur Hall of Fame for his work in sleep and respiratory medicine, the company announced Feb. 19. In 1989, Farrell established San Diego-based ResMed to treat sleep-disordered breathing. The eighth inductee into the CONNECT Entrepreneur Hall of Fame, he has served the San Diego community through a variety of philanthropic efforts. CONNECT supports innovative technology and life sciences work in San Diego County.

CONNECT Entrepreneur Hall of Fame, Peter Farrell, ResMed


Read Full Articlered right arrow icon

Also Noted

ResMed director sells $1.2m in company stock

September 10, 2013HME News Staff

SAN DIEGO - Peter Farrell, ResMed director, sold 25,000 shares of stock on Sept. 5. At $48 apiece, the stock went for $1.2 million, according to Ticker Report, which says Farrell now directly owns 511,825 shares in ResMed. Shares of ResMed traded up 3.09% on Sept. 9, hitting $50.67. ResMed has a one year low of $38.08 and a one year high of $51.40.

Peter Farrell, ResMed, stock


Also Noted

ResMed promotes Michael Farrell to CEO

February 21, 2013HME News Staff

POWAY, Calif. - Michael “Mick” Farrell, president of ResMed's Americas division since 2011, will replace his father, Peter Farrell, as CEO and be appointed to the company's board effective March 1, according to a press release. Peter Farrell will remain executive chairman through the end of the year, then non-executive chairman. “It was easily determined that members of the very talented and experienced team that have driven much of the company's great success over the past decade...

Mick Farrell, Peter Farrell, ResMed


Read Full Articlered right arrow icon

Also Noted

ResMed CEO sells 400,000 shares

February 6, 2013HME News Staff

SAN DIEGO - ResMed CEO and Executive Chairman Peter Farrell sold 400,000 shares at an average price of $46.98 on Jan. 30, according to an article from Nasdaq.com. Farrell made the sale the same day CMS announced a reimbursement cut of, on average, 45% as part of Round 2 of competitive bidding, which drove ResMed's stock price to drop more than 6%.

Competitive Bidding, Nasdaq, Peter Farrell, ResMed, round 2


Vendors

ResMed reports double-digit increases

January 25, 2013Liz Beaulieu, Editor

SAN DIEGO - With home sleep testing (HST) gaining ground and new products in the works, 2013 should be a good year for ResMed, officials reported last week.During a conference call to discuss its quarterly earnings (see below), Chairman and CEO Peter Farrell noted that he expects up to 50% of all sleep tests will be conducted in the home by end of the year.“We've been pioneering a market dynamic for several years that is finally getting traction,” he said.Driving that growth: By this...

APAP, CPAP, HST, Peter Farrell, ResMed


Read Full Articlered right arrow icon

Also Noted

ResMed to select new CEO in early 2013

December 26, 2012HME News Staff

SAN DIEGO - ResMed is on track to choose an internal candidate as its next CEO in early 2013, The Australian has reported. The two candidates vying for the position: Michael Farrell, president of Americas; and Robert Douglas, COO. Founder and outgoing boss Peter Farrell said that recruiters are in the process of preparing a final report that will be presented to the board next month, and that a vote will likely take place at a board meeting in February.

Michael Farrell, Peter Farrell, ResMed, Robert Douglas


Also Noted

ResMed mulls move

December 6, 2012HME News Staff

SAN DIEGO - ResMed is evaluating whether it should move its headquarters out of California, according to news reports. Peter Farrell, ResMed CEO, cited tax increases, stronger unions, stricter regulations and a Democratic majority in the state legislature as reasons why the company is looking elsewhere. A board-appointed task force is considering Texas, South Carolina, Singapore and Ireland as potential future bases for the company. “We're trying to evaluate whether or not it's the best thing...

Peter Farrell, ResMed


Read Full Articlered right arrow icon

Also Noted

ResMed announces record quarter

October 26, 2012HME News Staff

SAN DIEGO - ResMed this week reported revenue of $339.7 million for the quarter ended Sept. 30, 2012, an 8% increase over the same quarter last year. Net income was $71.3 million, a 41% increase; and earnings per share were $0.49, a 48% increase. “In the first quarter of fiscal 2013 we showed strong year-over-year growth on the top and bottom lines, and both our flow generator and mask categories did well,” stated Peter Farrell, Ph.D., chairman and CEO of ResMed, in a press release. “Revenue...

Peter Farrell, ResMed


Read Full Articlered right arrow icon